| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 215,635 | 216,084 | 215,595 | 214,871 | | Cost of Revenue | 47,669 | 46,983 | 45,282 | 46,897 | | | Gross Profit | 167,966 | 169,101 | 170,313 | 167,974 | | | Operating Expenses | | Research Development | 45,756 | 45,683 | 44,552 | 45,392 | | Selling General and Administrative | 95,708 | 100,817 | 100,729 | 101,089 | | Non Recurring | 293,317 | 1,227 | 7,408 | 7,849 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (259,134) | 21,374 | 17,624 | 13,644 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,751 | 3,714 | 3,971 | 5,499 | | Earnings Before Interest And Taxes | (269,800) | 25,088 | 21,595 | 19,143 | | Interest Expense | (11,482) | 4,580 | 3,767 | 3,135 | | Income Before Tax | (258,318) | 20,508 | 17,828 | 16,008 | | Income Tax Expense | (2,629) | 4,151 | 2,777 | 6,367 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (255,689) | 16,357 | 15,051 | 9,641 | | | Non-recurring Events | | Discontinued Operations |
-
| 302 | 566 | 1,036 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (255,689) | 16,659 | 15,617 | 10,677 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($255,689) | $16,659 | $15,617 | $10,677 |
|
0.51% Nasdaq 
Income Statement
